Company intelligence / Profile preview

SiMPore

West Henrietta, New York, United Statessimpore.com ↗

Ownership: Private
Employees: ~18
Development stage: Commercial

Overview

SiMPore has developed proprietary silicon nanomembranes and BioMEMS technologies used in life sciences and materials science research. Their products enable high-resolution analysis, filtration, cell culture studies, electron microscopy sample prep, microplastic analysis, and more. The company’s solutions are widely adopted by researchers to improve data quality in biomedical and environmental studies.

Modalities: DeviceNanoparticle
Industry: Non-Drug Biotech

Partnerships

Not publicly disclosed; no major pharma/biotech partnerships identified.

Beyond the preview

Go deeper on SiMPore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SiMPore.

Explore the full profile